EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
162 hedge funds and large institutions have $573M invested in Eagle Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 67 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
162
Holders Change
+11
Holders Change %
+7.28%
% of All Funds
2.5%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
22
Increased
48
Reduced
67
Closed
10
Calls
$693K
Puts
–
Net Calls
+$693K
Net Calls Change
-$941K
Top Buyers
| 1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$13.6M |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$3.85M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$4.72M |
| 4 |
4
Pacer Advisors
Malvern,
Pennsylvania
|
$1.32M |
| 5 |
5
Charles Schwab
San Francisco,
California
|
$4.95M |
